These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 20693075)
21. Immunohistochemistry of LAMP-2 and adipophilin for phospholipidosis in liver and kidney in ketoconazole-treated mice. Asaoka Y; Togashi Y; Imura N; Sai T; Miyoshi T; Miyamoto Y Exp Toxicol Pathol; 2013 Sep; 65(6):817-23. PubMed ID: 23276623 [TBL] [Abstract][Full Text] [Related]
22. Characterization of the anticonvulsant profile and enantioselective pharmacokinetics of the chiral valproylamide propylisopropyl acetamide in rodents. Isoherranen N; Yagen B; Woodhead JH; Spiegelstein O; Blotnik S; Wilcox KS; Finnell RH; Bennett GD; White HS; Bialer M Br J Pharmacol; 2003 Feb; 138(4):602-13. PubMed ID: 12598414 [TBL] [Abstract][Full Text] [Related]
23. Isolation of lamellar bodies from rat granular pneumocytes in primary culture. Chander A; Dodia CR; Gil J; Fisher AB Biochim Biophys Acta; 1983 Aug; 753(1):119-29. PubMed ID: 6411126 [TBL] [Abstract][Full Text] [Related]
24. From the Cover: Potentiation of Drug-Induced Phospholipidosis In Vitro through PEGlyated Graphene Oxide as the Nanocarrier. Yang L; Zhong X; Li Q; Zhang X; Wang Y; Yang K; Zhang LW Toxicol Sci; 2017 Mar; 156(1):39-53. PubMed ID: 28013220 [TBL] [Abstract][Full Text] [Related]
25. The dispositional enantioselectivity of indobufen in rat and mouse. Strolin Benedetti M; Moro E; Frigerio E; Jannuzzo MG; Roncucci R; Caldwell J Biochem Pharmacol; 1990 Oct; 40(8):1719-23. PubMed ID: 2242009 [TBL] [Abstract][Full Text] [Related]
26. An improved procedure for the isolation of lamellar bodies from human lung. Lamellar bodies free of lysosomes contain a spectrum of lysosomal-type hydrolases. de Vries AC; Schram AW; van den Berg M; Tager JM; Batenburg JJ; van Golde LM Biochim Biophys Acta; 1987 Dec; 922(3):259-69. PubMed ID: 3689811 [TBL] [Abstract][Full Text] [Related]
27. Insight into stereoselective disposition of enantiomers of a potent antithrombotic agent, S002-333 following administration of the racemic compound to mice. Bhateria M; Rachumallu R; Yerrabelli S; Saxena AK; Bhatta RS Eur J Pharm Sci; 2017 Apr; 101():107-114. PubMed ID: 28189817 [TBL] [Abstract][Full Text] [Related]
28. Enhanced Mechanical and Thermal Strength in Mixed-Enantiomers-Based Supramolecular Gel. Tómasson DA; Ghosh D; Kržišnik Z; Fasolin LH; Vicente AA; Martin AD; Thordarson P; Damodaran KK Langmuir; 2018 Oct; 34(43):12957-12967. PubMed ID: 30272986 [TBL] [Abstract][Full Text] [Related]
29. Stereochemistry and neuropharmacology of a 'bath salt' cathinone: S-enantiomer of mephedrone reduces cocaine-induced reward and withdrawal in invertebrates. Vouga A; Gregg RA; Haidery M; Ramnath A; Al-Hassani HK; Tallarida CS; Grizzanti D; Raffa RB; Smith GR; Reitz AB; Rawls SM Neuropharmacology; 2015 Apr; 91():109-16. PubMed ID: 25496724 [TBL] [Abstract][Full Text] [Related]
30. Reversible, hepatic, lysosomal phospholipidosis in rat induced by subchronic daily administration of trospectomycin sulfate. Cox JW; Ulrich RG; Wynalda MA; McKenna R; Larsen ER; Ginsberg LC; Epps DE Biochem Pharmacol; 1989 Oct; 38(20):3535-41. PubMed ID: 2530987 [TBL] [Abstract][Full Text] [Related]
31. Preparation and antitumour properties of the enantiomers of a hypoxia-selective nitro analogue of the duocarmycins. Tercel M; Lee HH; Yang S; Liyanage HD; Mehta SY; Boyd PD; Jaiswal JK; Tan KL; Pruijn FB ChemMedChem; 2011 Oct; 6(10):1860-71. PubMed ID: 21793220 [TBL] [Abstract][Full Text] [Related]
32. An introduction to enantiomers in psychopharmacology. Leonard BE Hum Psychopharmacol; 2001 Dec; 16(S2):S79-S84. PubMed ID: 12404712 [TBL] [Abstract][Full Text] [Related]
33. Permeability of pure enantiomers of ketorolac through human cadaver skin. Roy SD; Chatterjee DJ; Manoukian E; Divor A J Pharm Sci; 1995 Aug; 84(8):987-90. PubMed ID: 7500285 [TBL] [Abstract][Full Text] [Related]
34. Formation of the racemic compound of ephedrine base from a physical mixture of its enantiomers in the solid, liquid, solution, or vapor state. Duddu SP; Grant DJ Pharm Res; 1992 Aug; 9(8):1083-91. PubMed ID: 1409382 [TBL] [Abstract][Full Text] [Related]
35. Stereoselective pharmacokinetics of ornidazole after intravenous administration of individual enantiomers and the racemate. Chen Y; Liu XQ; Zhong J; Zhao X; Wang Y; Wang G Chirality; 2006 Nov; 18(10):799-802. PubMed ID: 16906493 [TBL] [Abstract][Full Text] [Related]
36. In vivo and in vitro reversibility of chlorphentermine-induced phospholipidosis in rat alveolar macrophages. McCloud CM; Beard TL; Kacew S; Reasor MJ Exp Mol Pathol; 1995 Feb; 62(1):12-21. PubMed ID: 7556587 [TBL] [Abstract][Full Text] [Related]
37. Relationship between in vitro phospholipidosis assay using HepG2 cells and 2-week toxicity studies in rats. Miyamoto S; Matsumoto A; Mori I; Horinouchi A Toxicol Mech Methods; 2009 Oct; 19(8):477-85. PubMed ID: 19793005 [TBL] [Abstract][Full Text] [Related]
38. Stereoselective pharmacokinetics of BOF-4272 racemate after oral administration to rats and dogs. Naito S; Nishimura M Biol Pharm Bull; 2002 May; 25(5):674-7. PubMed ID: 12033515 [TBL] [Abstract][Full Text] [Related]
39. An enantiomer-enantiomer interaction of (S)- and (R)-propafenone modifies the effect of racemic drug therapy. Kroemer HK; Fromm MF; Bühl K; Terefe H; Blaschke G; Eichelbaum M Circulation; 1994 May; 89(5):2396-400. PubMed ID: 7910120 [TBL] [Abstract][Full Text] [Related]
40. Disobutamide: a model agent for investigating intracellular drug storage. Ruben Z; Dodd DC; Rorig KJ; Anderson SN Toxicol Appl Pharmacol; 1989 Jan; 97(1):57-71. PubMed ID: 2464862 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]